SAN FRANCISCO, March 29, 2018 /PRNewswire/ --
The global breast imaging market is expected to reach USD 7.3 billion by 2024, according to a new report by Grand View Research, Inc. Increasing prevalence of breast cancer and supportive government initiatives to increase awareness are expected to boost demand in the market.
Supportive government initiatives such UK government campaign's "Be clear on cancer," which helped in spreading awareness about the risk factors, preventive measures, and early diagnosis of cancer. This campaign also included free screening programs, which helped in diagnosing around 15,000 cancer patients.
Technological advancements in the imaging sector are expected to boost growth in the market. Companies such as Gamma Medica, Dilon Technologies, and SonoCine are completely dedicated to developing improved technologies in the field of breast imaging. The innovation of complimentary products such as the breast pad designed by GE Healthcare to provide comfort to a woman undergoing screening is expected to catalyze the market growth further.
Browse full research report with TOC on "Breast Imaging Market Size, Share & Trend Analysis Report By Technology (Ionizing Technology, Non-Ionizing Technology), And Segment Forecasts, 2013 - 2024" at: https://www.grandviewresearch.com/industry-analysis/breast-imaging-equipment-market
Further Key Findings From the Report Suggest:
Browse related reports by Grand View Research:
Grand View Research has segmented the global breast imaging market on the basis of technology and region:
Read Our Blog By Grand View Research: https://www.grandviewresearch.com/blogs/healthcare
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc. Phone: +1-415-349-0058 Toll Free: 1-888-202-9519 Email: email@example.com
SOURCE Grand View Research, Inc.
Subscribe to our Free Newsletters!
Tracheal or windpipe cancer is a rare cancer and its cause is unclear. The most common squamous ...
Tecovirimat can be used to treat smallpox disease in adult and pediatric patients who weigh at ...
Blount's disease is a developmental disorder in which the shinbone is affected, resulting in ...View All